()GMP~1
- 格式:doc
- 大小:60.00 KB
- 文档页数:4
中华人民共和国卫生部令 第 79 号 《药品生产质量管理规范(2010年修订)》已于2010年10月19日经卫生部部务会议审议通过,现予以发布,自2011年3月1日起施行。
部 长 陈竺 二○一一年一月十七日 第一章 总 则 第一条 为规范药品生产质量管理,根据《中华人民共和国药品管理法》、《中华人民共和国药品管理法实施条例》,制定本规范。
第二条 企业应当建立药品质量管理体系。
该体系应当涵盖影响药品质量的所有因素,包括确保药品质量符合预定用途的有组织、有计划的全部活动。
第三条 本规范作为质量管理体系的一部分,是药品生产管理和质量控制的基本要求,旨在最大限度地降低药品生产过程中污染、交叉污染以及混淆、差错等风险,确保持续稳定地生产出符合预定用途和注册要求的药品。
第四条 企业应当严格执行本规范,坚持诚实守信,禁止任何虚假、欺骗行为。
第二章 质量管理 第一节 原 则 第五条 企业应当建立符合药品质量管理要求的质量目标,将药品注册的有关安全、有效和质量可控的所有要求,系统地贯彻到药品生产、控制及产品放行、贮存、发运的全过程中,确保所生产的药品符合预定用途和注册要求。
第六条 企业高层管理人员应当确保实现既定的质量目标,不同层次的人员以及供应商、经销商应当共同参与并承担各自的责任。
第七条 企业应当配备足够的、符合要求的人员、厂房、设施和设备,为实现质量目标提供必要的条件。
第二节 质量保证 第八条 质量保证是质量管理体系的一部分。
企业必须建立质量保证系统,同时建立完整的文件体系,以保证系统有效运行。
第九条 质量保证系统应当确保: (一)药品的设计与研发体现本规范的要求; (二)生产管理和质量控制活动符合本规范的要求; (三)管理职责明确; (四)采购和使用的原辅料和包装材料正确无误; (五)中间产品得到有效控制; (六)确认、验证的实施; (七)严格按照规程进行生产、检查、检验和复核; (八)每批产品经质量受权人批准后方可放行; (九)在贮存、发运和随后的各种操作过程中有保证药品质量的适当措施; (十)按照自检操作规程,定期检查评估质量保证系统的有效性和适用性。
《药品 GMP认证检查评定标准》一、药品GMP认证检查项目共259 项,其中关键项目(条款号前加“* ”) 92 项,一般项目167 项。
二、药品GMP认证检查时,应根据申请认证的范围确定相应的检查项目, 并进行全面检查和评定。
三、检查中发现不符合要求的项目统称为“缺陷项目”。
其中,关键项目不符合要求者称为“严重缺陷”,一般项目不符合要求者称为“一般缺陷”。
四、缺陷项目如果在申请认证的各剂型或产品中均存在,应按剂型或产品分别计算。
五、在检查过程中,企业隐瞒有关情况或提供虚假材料的,按严重缺陷处理。
检查组应调查取证并详细记录。
六、结果评定(一)未发现严重缺陷,且一般缺陷≤20%,能够立即改正的, 企业必须立即改正;不能立即改正的 , 企业必须提供缺陷整改报告及整改计划,方可通过药品GMP认证。
(二)严重缺陷或一般缺陷>20%的,不予通过药品GMP认证。
药品 GMP认证检查项目序号条款检查内容机构与人员1*0301企业应建立药品生产和质量管理机构,明确各级机构和人员的职责。
20302企业应配备一定数量的与药品生产相适应的具有相应的专业知识、生产经验及工作能力,应能正确履行其职责的管理人员和技术人员,主管生产和质量管理的企业负责人应具有医药或相关专业大专以上3*0401学历,并具有药品生产和质量管理经验,应对本规范的实施和产品质量负责。
生物制品生产企业生产和质量管理负责人应具有相应的专业知识(细4*0402菌学、病毒学、生物学、分子生物学、生物化学、免疫学、医学、药学等),并有丰富的实践经验以确保在其生产、质量管理中履行其职责。
5*0403中药制剂生产企业主管药品生产和质量管理的负责人应具有中药专业知识。
生产管理和质量管理的部门负责人应具有医药或相关专业大专以上6*0501学历,并具有药品生产和质量管理的实践经验,有能力对药品生产和质量管理中的实际问题做出正确的判断和处理。
7*0502药品生产管理部门和质量管理部门负责人不得互相兼任。
襄樊职业技术学院《GMP》课程标准一、课程基本信息课程代码:SGMP 课程类型:B 学分:4总课时:60 理论课时:48 实践课时:12教学场地要求:校内标准教室、校内GMP实训中心、隆中药厂任课教师要求:(1)教师应具备药学专业或药学相关专业本科及以上学历,具有高等学校教师资格证书。
(2)专业实训课教师应具备药学专业或药学相关专业职业资格证书或相应技术职称。
二、课程定位《GMP》是生物制药技术专业的专业核心课之一,是一门理论兼应用型专业课程。
本课程的教学是药品生产质量控制,厂房设计,设备管理等职业岗位要求设计组织教学内容,以药品生产过程设计课程单元。
通过本课程的学习,使学生具备从事药品生产、设备仪器使用,厂房设计维护的基本知识和基本技能;具备药品GMP的基本知识与基本技能,培养学生的药品安全生产质量意识,旨在药品生产企业培养能生产懂管理的高素质技能型人才奠定基础。
前导课程有《药物制剂技术》,《天然药物化学》《中药炮制技术》。
此课程为学生进入药厂工作培养了依法从事药品生产,具备规范从事药品生产的知识和能力。
三、课程目标1.知识目标(1)掌握GMP管理制度的内容(2)认识药品质量检验过程中的管理要求和实施方法。
(3)清楚物料接受,物料储存和物料发放各环节的管理要求和实施方法。
(4)知晓生产前准备,生产过程和生产结束各环节的管理和实施方法。
2.能力目标(1)遵守GMP规定,依法从事物料验收,入库发放。
(2)按GMP要求,对药品质量进行检验。
(3)按GMP要求,对生产人员进行培训,考核。
(4)按GMP要求,对机构进行设置。
3.态度目标(1)树立“依法制药、规范生产”的观念,培养严谨细致、认真负责的工作态度。
(2)严格执行 GMP 管理,养成实事求是、一丝不苟的职业习惯。
(3)善于沟通和合作的品质,树立环保、节能、质量第一和安全生产的意识。
四、课程设计1、设计思想课程打破了以知识传授为主要特征的传统学科课程模式,转变为以任务引领型课程为主体的内容模式,目的让学生通过完成具体项目来构建相关理论知识,发展职业能力。
EUROPEAN COMMISSIONENTERPRISE AND INDUSTRY DIRECTORATE-GENERALConsumer goodsPharmaceuticalsBrussels, 25 November 2008 (rev.)EudraLexThe Rules Governing Medicinal Products in the European UnionVolume 4EU Guidelines toGood Manufacturing PracticeMedicinal Products for Human and Veterinary UseAnnex 1Manufacture of Sterile Medicinal Products(corrected version)Document HistoryPrevious version dated 30 May 2003, in operation since September 2003Revision to align classification table of clean rooms, to include guidance on media simultations, bioburden monitoring and capping of vials November 2005 to December 2007Date for coming into operation and superseding 01 March 20091 Please note correction on the implementation of provisions for capping of vials!1Note: Provisions on capping of vials should be implemented by 01 March 2010.Commission Européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel – Belgium. Telephone: (32-2) 299 11 11ANNEX 1MANUFACTURE OF STERILE MEDICINAL PRODUCTSPrincipleThe manufacture of sterile products is subject to special requirements in order to minimize risks of microbiological contamination, and of particulate and pyrogen contamination. Much depends on the skill, training and attitudes of the personnel involved. Quality Assurance is particularly important, and this type of manufacture must strictly follow carefully established and validated methods of preparation and procedure. Sole reliance for sterility or other quality aspects must not be placed on any terminal process or finished product test.Note:This guidance does not lay down detailed methods for determining the microbiological and particulate cleanliness of air, surfaces etc. Reference should be made to other documents such as the EN/ISO Standards.General1. The manufacture of sterile products should be carried out in clean areas entry to which should be through airlocks for personnel and/or for equipment and materials. Clean areas should be maintained to an appropriate cleanliness standard and supplied with air which has passed through filters of an appropriate efficiency.2. The various operations of component preparation, product preparation and filling should be carried out in separate areas within the clean area. Manufacturing operations are divided into two categories; firstly those where the product is terminally sterilised, and secondly those which are conducted aseptically at some or all stages.3. Clean areas for the manufacture of sterile products are classified according to the required characteristics of the environment. Each manufacturing operation requires an appropriate environmental cleanliness level in the operational state in order to minimise the risks of particulate or microbial contamination of the product or materials being handled.In order to meet “in operation” conditions these areas should be designed to reach certain specified air-cleanliness levels in the “at rest” occupancy state. The “at-rest” state is the condition where the installation is installed and operating, complete with production equipment but with no operating personnel present. The “in operation” state is the condition where the installation is functioning in the defined operating mode with the specified number of personnel working.The “in operation” and “at rest” states should be defined for each clean room or suite of clean rooms.For the manufacture of sterile medicinal products 4 grades can be distinguished.Grade A: The local zone for high risk operations, e.g. filling zone, stopper bowls, open ampoules and vials, making aseptic connections. Normally such conditions are provided by a laminar air flow work station. Laminar air flow systems should provide a homogeneous air speed in a range of 0.36 – 0.54 m/s (guidance value) at the working position in open clean room applications. The maintenance of laminarity should be demonstrated and validated.A uni-directional air flow and lower velocities may be used in closed isolators and glove boxes.Grade B: For aseptic preparation and filling, this is the background environment for the gradeA zone.Grade C and D: Clean areas for carrying out less critical stages in the manufacture of sterile products.Clean room and clean air device classification4. Clean rooms and clean air devices should be classified in accordance with EN ISO 14644-1. Classification should be clearly differentiated from operational process environmental monitoring. The maximum permitted airborne particle concentration for each grade is given in the following table.Maximum permitted number of particles per m 3 equal to or greater than the tabulated sizeAt rest In operation Grade0.5 µm 5.0µm 0.5 µm 5.0µm A3 520 20 3 520 20 B3 520 29 352 000 2 900 C352 000 2 900 3 520 000 29 000 D3 520 000 29 000 Not defined Not defined 5. For classification purposes in Grade A zones, a minimum sample volume of 1m 3 should be taken per sample location. For Grade A the airborne particle classification is ISO 4.8 dictated by the limit for particles ≥5.0 µm. For Grade B (at rest) the airborne particle classification is ISO 5 for both considered particle sizes. . For Grade C (at rest & in operation) the airborne particle classification is ISO 7 and ISO 8 respectively. For Grade D (at rest) the airborne particle classification is ISO 8. For classification purposes EN/ISO 14644-1 methodology defines both the minimum number of sample locations and the sample size based on the class limit of the largest considered particle size and the method of evaluation of the data collected.6. Portable particle counters with a short length of sample tubing should be used for classification purposes because of the relatively higher rate of precipitation of particles ≥5.0µm in remote sampling systems with long lengths of tubing. Isokinetic sample heads shall be used in unidirectional airflow systems.7. “In operation” classification may be demonstrated during normal operations, simulated operations or during media fills as worst-case simulation is required for this. EN ISO 14644-2 provides information on testing to demonstrate continued compliance with the assigned cleanliness classifications.Clean room and clean air device monitoring8. Clean rooms and clean air devices should be routinely monitored in operation and the monitoring locations based on a formal risk analysis study and the results obtained during the classification of rooms and/or clean air devices.9. For Grade A zones, particle monitoring should be undertaken for the full duration of critical processing, including equipment assembly, except where justified by contaminants in theprocess that would damage the particle counter or present a hazard, e.g. live organisms and radiological hazards. In such cases monitoring during routine equipment set up operations should be undertaken prior to exposure to the risk. Monitoring during simulated operations should also be performed. The Grade A zone should be monitored at such a frequency and with suitable sample size that all interventions, transient events and any system deterioration would be captured and alarms triggered if alert limits are exceeded. It is accepted that it may not always be possible to demonstrate low levels of ≥5.0 µm particles at the point of fill when filling is in progress, due to the generation of particles or droplets from the product itself. 10. It is recommended that a similar system be used for Grade B zones although the sample frequency may be decreased. The importance of the particle monitoring system should be determined by the effectiveness of the segregation between the adjacent Grade A and B zones. The Grade B zone should be monitored at such a frequency and with suitable sample size that changes in levels of contamination and any system deterioration would be captured and alarms triggered if alert limits are exceeded.11. Airborne particle monitoring systems may consist of independent particle counters; a network of sequentially accessed sampling points connected by manifold to a single particle counter; or a combination of the two. The system selected must be appropriate for the particle size considered. Where remote sampling systems are used, the length of tubing and the radii of any bends in the tubing must be considered in the context of particle losses in the tubing. The selection of the monitoring system should take account of any risk presented by the materials used in the manufacturing operation, for example those involving live organisms or radiopharmaceuticals.12. The sample sizes taken for monitoring purposes using automated systems will usually be a function of the sampling rate of the system used. It is not necessary for the sample volume to be the same as that used for formal classification of clean rooms and clean air devices.13. In Grade A and B zones, the monitoring of the ≥5.0 µm particle concentration count takes on a particular significance as it is an important diagnostic tool for early detection of failure. The occasional indication of ≥5.0 µm particle counts may be false counts due to electronic noise, stray light, coincidence, etc. However consecutive or regular counting of low levels is an indicator of a possible contamination event and should be investigated. Such events may indicate early failure of the HVAC system, filling equipment failure or may also be diagnostic of poor practices during machine set-up and routine operation.14. The particle limits given in the table for the “at rest” state should be achieved after a short “clean up” period of 15-20 minutes (guidance value) in an unmanned state after completion of operations.15. The monitoring of Grade C and D areas in operation should be performed in accordance with the principles of quality risk management. The requirements and alert/action limits will depend on the nature of the operations carried out, but the recommended “clean up period” should be attained.16. Other characteristics such as temperature and relative humidity depend on the product and nature of the operations carried out. These parameters should not interfere with the defined cleanliness standard.17. Examples of operations to be carried out in the various grades are given in the table below (see also paragraphs 28 to 35):Grade Examples of operations for terminally sterilised products. (see paragraphs 28-30)A Filling of products, when unusually at riskC Preparation of solutions, when unusually at risk. Filling of productsD Preparation of solutions and components for subsequent fillingGrade Examples of operations for aseptic preparations. (see paragraphs. 31-35)A Aseptic preparation and filling.C Preparationofsolutions to be filtered.D Handling of components after washing.18. Where aseptic operations are performed monitoring should be frequent using methods such as settle plates, volumetric air and surface sampling (e.g. swabs and contact plates). Sampling methods used in operation should not interfere with zone protection. Results from monitoring should be considered when reviewing batch documentation for finished product release. Surfaces and personnel should be monitored after critical operations. Additional microbiological monitoring is also required outside production operations, e.g. after validation of systems, cleaning and sanitisation.19. Recommended limits for microbiological monitoring of clean areas during operation:Recommended limits for microbial contamination (a)Grade air samplecfu/m3settle plates(diameter 90 mm)cfu/4 hours (b)contact plates(diameter 55 mm)cfu/plateglove print5 fingerscfu/gloveA < 1 < 1 < 1 < 1B 10 5 5 5C 100 50 25 -D 200 100 50 -Notes(a) These are average values.(b) Individual settle plates may be exposed for less than 4 hours.20. Appropriate alert and action limits should be set for the results of particulate and microbiological monitoring. If these limits are exceeded operating procedures should prescribe corrective action.Isolator technology21. The utilisation of isolator technology to minimize human interventions in processing areas may result in a significant decrease in the risk of microbiological contamination of aseptically manufactured products from the environment. There are many possible designs of isolators and transfer devices. The isolator and the background environment should be designed so that the required air quality for the respective zones can be realised. Isolators are constructed of various materials more or less prone to puncture and leakage. Transfer devices may vary from a single door to double door designs to fully sealed systems incorporating sterilisation mechanisms.22. The transfer of materials into and out of the unit is one of the greatest potential sources of contamination. In general the area inside the isolator is the local zone for high risk manipulations, although it is recognised that laminar air flow may not exist in the working zone of all such devices.23. The air classification required for the background environment depends on the design of the isolator and its application. It should be controlled and for aseptic processing it should be at least grade D.24. Isolators should be introduced only after appropriate validation. Validation should take into account all critical factors of isolator technology, for example the quality of the air inside and outside (background) the isolator, sanitisation of the isolator, the transfer process and isolator integrity.25. Monitoring should be carried out routinely and should include frequent leak testing of the isolator and glove/sleeve system.Blow/fill/seal technology26. Blow/fill/seal units are purpose built machines in which, in one continuous operation, containers are formed from a thermoplastic granulate, filled and then sealed, all by the one automatic machine. Blow/fill/seal equipment used for aseptic production which is fitted with an effective grade A air shower may be installed in at least a grade C environment, provided that grade A/B clothing is used. The environment should comply with the viable and non viable limits at rest and the viable limit only when in operation. Blow/fill/seal equipment used for the production of products which are terminally sterilised should be installed in at least a grade D environment.27. Because of this special technology particular attention should be paid to, at least the following:•equipment design and qualification•validation and reproducibility of cleaning-in-place and sterilisation-in-place•background clean room environment in which the equipment is located•operator training and clothing•interventions in the critical zone of the equipment including any aseptic assembly prior to the commencement of filling.Terminally sterilised products28. Preparation of components and most products should be done in at least a grade D environment in order to give low risk of microbial and particulate contamination, suitable for filtration and sterilisation. Where the product is at a high or unusual risk of microbial contamination, (for example, because the product actively supports microbial growth or must be held for a long period before sterilisation or is necessarily processed not mainly in closed vessels), then preparation should be carried out in a grade C environment.29. Filling of products for terminal sterilisation should be carried out in at least a grade C environment.30. Where the product is at unusual risk of contamination from the environment, for example because the filling operation is slow or the containers are wide-necked or are necessarily exposed for more than a few seconds before sealing, the filling should be done in a grade A zone with at least a grade C background. Preparation and filling of ointments, creams,suspensions and emulsions should generally be carried out in a grade C environment before terminal sterilisation.Aseptic preparation31. Components after washing should be handled in at least a grade D environment. Handling of sterile starting materials and components, unless subjected to sterilisation or filtration through a micro-organism-retaining filter later in the process, should be done in a grade A environment with grade B background.32. Preparation of solutions which are to be sterile filtered during the process should be done in a grade C environment; if not filtered, the preparation of materials and products should be done in a grade A environment with a grade B background.33. Handling and filling of aseptically prepared products should be done in a grade A environment with a grade B background.34. Prior to the completion of stoppering, transfer of partially closed containers, as used in freeze drying should be done either in a grade A environment with grade B background or in sealed transfer trays in a grade B environment.35. Preparation and filling of sterile ointments, creams, suspensions and emulsions should be done in a grade A environment, with a grade B background, when the product is exposed and is not subsequently filtered.Personnel36. Only the minimum number of personnel required should be present in clean areas; this is particularly important during aseptic processing. Inspections and controls should be conducted outside the clean areas as far as possible.37. All personnel (including those concerned with cleaning and maintenance) employed in such areas should receive regular training in disciplines relevant to the correct manufacture of sterile products. This training should include reference to hygiene and to the basic elements of microbiology. When outside staff who have not received such training (e.g. building or maintenance contractors) need to be brought in, particular care should be taken over their instruction and supervision.38. Staff who have been engaged in the processing of animal tissue materials or of cultures of micro-organisms other than those used in the current manufacturing process should not enter sterile-product areas unless rigorous and clearly defined entry procedures have been followed.39. High standards of personal hygiene and cleanliness are essential. Personnel involved in the manufacture of sterile preparations should be instructed to report any condition which may cause the shedding of abnormal numbers or types of contaminants; periodic health checks for such conditions are desirable. Actions to be taken about personnel who could be introducing undue microbiological hazard should be decided by a designated competent person.40. Wristwatches, make-up and jewellery should not be worn in clean areas.41. Changing and washing should follow a written procedure designed to minimize contamination of clean area clothing or carry-through of contaminants to the clean areas.42. The clothing and its quality should be appropriate for the process and the grade of the working area. It should be worn in such a way as to protect the product from contamination. 43. The description of clothing required for each grade is given below:•Grade D: Hair and, where relevant, beard should be covered. A general protective suit and appropriate shoes or overshoes should be worn. Appropriate measures should be taken to avoid any contamination coming from outside the clean area.•Grade C: Hair and where relevant beard and moustache should be covered. A single or two-piece trouser suit, gathered at the wrists and with high neck and appropriate shoes or overshoes should be worn. They should shed virtually no fibres or particulate matter.•Grade A/B: Headgear should totally enclose hair and, where relevant, beard and moustache; it should be tucked into the neck of the suit; a face mask should be worn to prevent the shedding of droplets. Appropriate sterilised, non-powdered rubber or plastic gloves and sterilised or disinfected footwear should be worn. Trouser-legs should be tucked inside the footwear and garment sleeves into the gloves. The protective clothing should shed virtually no fibres or particulate matter and retain particles shed by the body.44. Outdoor clothing should not be brought into changing rooms leading to grade B and C rooms. For every worker in a grade A/B area, clean sterile (sterilised or adequately sanitised) protective garments should be provided at each work session. Gloves should be regularly disinfected during operations. Masks and gloves should be changed at least for every working session.45. Clean area clothing should be cleaned and handled in such a way that it does not gather additional contaminants which can later be shed. These operations should follow written procedures. Separate laundry facilities for such clothing are desirable. Inappropriate treatment of clothing will damage fibres and may increase the risk of shedding of particles. Premises46. In clean areas, all exposed surfaces should be smooth, impervious and unbroken in order to minimize the shedding or accumulation of particles or micro-organisms and to permit the repeated application of cleaning agents, and disinfectants where used.47. To reduce accumulation of dust and to facilitate cleaning there should be no uncleanable recesses and a minimum of projecting ledges, shelves, cupboards and equipment. Doors should be designed to avoid those uncleanable recesses; sliding doors may be undesirable for this reason.48. False ceilings should be sealed to prevent contamination from the space above them.49. Pipes and ducts and other utilities should be installed so that they do not create recesses, unsealed openings and surfaces which are difficult to clean.50. Sinks and drains should be prohibited in grade A/B areas used for aseptic manufacture. In other areas air breaks should be fitted between the machine or sink and the drains. Floordrains in lower grade clean rooms should be fitted with traps or water seals to prevent back-flow.51. Changing rooms should be designed as airlocks and used to provide physical separation of the different stages of changing and so minimize microbial and particulate contamination of protective clothing. They should be flushed effectively with filtered air. The final stage of the changing room should, in the at-rest state, be the same grade as the area into which it leads. The use of separate changing rooms for entering and leaving clean areas is sometimes desirable. In general hand washing facilities should be provided only in the first stage of the changing rooms.52. Both airlock doors should not be opened simultaneously. An interlocking system or a visual and/or audible warning system should be operated to prevent the opening of more than one door at a time.53. A filtered air supply should maintain a positive pressure and an air flow relative to surrounding areas of a lower grade under all operational conditions and should flush the area effectively. Adjacent rooms of different grades should have a pressure differential of 10 - 15 pascals (guidance values). Particular attention should be paid to the protection of the zone of greatest risk, that is, the immediate environment to which a product and cleaned components which contact the product are exposed. The various recommendations regarding air supplies and pressure differentials may need to be modified where it becomes necessary to contain some materials, e.g. pathogenic, highly toxic, radioactive or live viral or bacterial materials or products. Decontamination of facilities and treatment of air leaving a clean area may be necessary for some operations.54. It should be demonstrated that air-flow patterns do not present a contamination risk, e.g. care should be taken to ensure that air flows do not distribute particles from a particle-generating person, operation or machine to a zone of higher product risk.55. A warning system should be provided to indicate failure in the air supply. Indicators of pressure differences should be fitted between areas where these differences are important. These pressure differences should be recorded regularly or otherwise documented. Equipment56. A conveyor belt should not pass through a partition between a grade A or B area and a processing area of lower air cleanliness, unless the belt itself is continually sterilised (e.g. in a sterilising tunnel).57. As far as practicable equipment, fittings and services should be designed and installed so that operations, maintenance and repairs can be carried out outside the clean area. If sterilisation is required, it should be carried out, wherever possible, after complete reassembly.58. When equipment maintenance has been carried out within the clean area, the area should be cleaned, disinfected and/or sterilised where appropriate, before processing recommences if the required standards of cleanliness and/or asepsis have not been maintained during the work.59. Water treatment plants and distribution systems should be designed, constructed and maintained so as to ensure a reliable source of water of an appropriate quality. They should not be operated beyond their designed capacity. Water for injections should be produced,stored and distributed in a manner which prevents microbial growth, for example by constant circulation at a temperature above 70°C.60. All equipment such as sterilisers, air handling and filtration systems, air vent and gas filters, water treatment, generation, storage and distribution systems should be subject to validation and planned maintenance; their return to use should be approved.Sanitation61. The sanitation of clean areas is particularly important. They should be cleaned thoroughly in accordance with a written programme. Where disinfectants are used, more than one type should be employed. Monitoring should be undertaken regularly in order to detect the development of resistant strains.62. Disinfectants and detergents should be monitored for microbial contamination; dilutions should be kept in previously cleaned containers and should only be stored for defined periods unless sterilised. Disinfectants and detergents used in Grades A and B areas should be sterile prior to use.63. Fumigation of clean areas may be useful for reducing microbiological contamination in inaccessible places.Processing64. Precautions to minimize contamination should be taken during all processing stages including the stages before sterilisation.65. Preparations of microbiological origin should not be made or filled in areas used for the processing of other medicinal products; however, vaccines of dead organisms or of bacterial extracts may be filled, after inactivation, in the same premises as other sterile medicinal products.66. Validation of aseptic processing should include a process simulation test using a nutrient medium (media fill).Selection of the nutrient medium should be made based on dosage form of the product and selectivity, clarity, concentration and suitability for sterilisation of the nutrient medium.67. The process simulation test should imitate as closely as possible the routine aseptic manufacturing process and include all the critical subsequent manufacturing steps. It should also take into account various interventions known to occur during normal production as well as worst-case situations.68. Process simulation tests should be performed as initial validation with three consecutive satisfactory simulation tests per shift and repeated at defined intervals and after any significant modification to the HVAC-system, equipment, process and number of shifts. Normally process simulation tests should be repeated twice a year per shift and process.69. The number of containers used for media fills should be sufficient to enable a valid evaluation. For small batches, the number of containers for media fills should at least equal the size of the product batch. The target should be zero growth and the following should apply:。
医药制品GMP检查的培训
GMP认证员和QA管理者的工作会议前评估
学员编号: 单位:
分数:
姓名: 职务:
请在30分钟内回答下列25个问题,单选题。请将正确答案在答题纸上清楚的圈出,如果错选时,请在错
选的答案上划一横线再将正确答案圈出。
1. 质量管理的概念包括:
(A) 仅指质量控制
(B) 仅指质量保证
(C) 包括GMP和质量控制
(D) 包括质量保证、质量控制和GMP
2. GMP主要指:
(A) 保证所有产品按照规程检测
(B) 保证所有产品按照配方生产
(C) 降低生产过程中潜在的且不能通过成品检验来避免的风险
(D) 仅用于避免交叉污染
3. 质量控制部门所担负的其他职责包括:
(A) 处理关于餐厅食品质量问题的投诉
(B) 建立验证和执行所有质控的方法并确保活性成分的稳定性和产品是可监控的
(C) 处理有关市场对产品使用后的质量投诉
(D) 以上全是
4. 成品评价的内容包括:
(A) 包括对生产过程检测的结果,对生产、包装和质量控制文件的评估以及对符合标准规定制品投
诉的评估
(B) 包括对设备设计及许可的评价
(C) 如其他各项检测结果满意,应不包括产品最终包装的检测
(D) 以上全是
5. GMP 检查员应确保消毒剂的选择:
(A) 按该公司一贯的使用标准,包含于清洁及消毒的标准操作规程中
(B) 能买到的最贵的消毒剂
(C) 用于手部清洁最好的一种
(D) 当时能使用的任何一种
6. 清场检查应在如下时候进行:
(A) 每批生产完毕时
(B) 每班结束时.
(C) 每批生产开始时
(D) 以上全是
7. 主验证计划的目的是:
(A)列出整个验证程序的检测项目和接受标准
(B) 提供一份验证方针的概览
(C) 记录验证过程中的测试结果
(D) 包括以上各项
8. 在线验证在如下什么情况下执行:
(A) 定期的和/或在发生重大改变时
(B) 按常规执行的生产过程
(C) 在开发阶段
(D) 在每批产品的正常生产过程中.
9. 召回产品应:
(A) 如果该公司有验证的计算机库房管理系统,则可存放在主货仓的任何地方
(B) 必须存放在隔离区内
(C) 可以扔在厂外,因其没有任何价值
(D) 在决定如何处理的过程中,必须将其保存在一个被安全隔离的地方
10. 自检应在如下情况下进行:
(A) 只作为政府GMP检查的一次额外检查
(B) 在每次停产过程中执行
(C) 一年进行一次,或在GMP认证员的指导下进行
(D) 按照一份合理的书面计划进行
11. 自检报告的目的是:
(A) 记录发现缺陷并提出整改意见,确保公司了解自身存在的G MP缺陷并进行及时的纠正,而不是
等待正式的政府检查
(B) 提供一份供管理者查阅并存档的文件
(C) 记录检查过程中的发现
(D) 以上全是
12. 生产和质量控制部门的负责人:
(A) 依据国家法规应共同承担某些责任
(B) 可以不用承担责任
(C) 两者之间谁的职位高向谁汇报
(D) 在对合同生产或分析的管理中,不发挥任何作用
13. GMP检查员到达时,公司应当:
(A) 事先就卫生和穿戴防护服装作特别说明,来访者应该严格接受监督
(B) 只要在公司陪同人员的密切监护下,应当允许他们去任何想去的正在生产的地方
(C) 鼓励他们取样进行质量检测
(D) 鼓励他们同操作人员交谈,让他们自己来发现实际的操作
14. 生产区的设计和安装:
(A) 应当在产品或原料所接触的环境提供光滑、无裂缝的墙壁、地板和天花板
(B) 应当安装开通式排水管以便于清洗
(C) 提供的布局应当适于维护,而不是便于产品流向
(D) 如果没有视觉检查要求,则不必有良好的照明
15. 存储区:
(A) 如果在这里取样的话,应当提供一个独立取样区,以避免取样时的交叉污染
(B) 如果需要,可以将待检材料放在不合格存储区存放几天
(C) 麻醉剂在整个储藏过程应不贴标签,从而使小偷难于发现
(D) 如果包装区标准很高,那么那些已印刷的包装材料就不需要任何特别注意
16. 收货单上,原材料:
(A) 应当予以检查,以确保交货托运同定货单相符
(B) 如发现有破损,只要送货司机说明货物完好,仍可接受
(C) 如果由相同原料的不同批次组成,则可视作同一批次进行抽样
(D) 在其通过质量控制检查以前,不须贴标签
17. 生产设备:
(A) 同产品相接触的部分不应影响产品的质量
(B) 如果仅用来生产同一种产品,则不必为易于清洗而进行专门设计
(C) 有缺陷的设备,如是房间内的唯一一台机器,则不必进行标记
(D) 如果仅用过一次来生产一种产品,那么发动机可以不清洗
18. 进厂的原材料应当:
(A) 如果是一种拯救生命产品所急需的,马上发放投入使用
(B) 收到后马上隔离直到发放使用为止
(C) 如在不被注意的情况下送到厂内,可以使用
(D) 按照财务部门为节省开支而制定的质量标准购买
19. 印刷的包装材料:
(A) 不需特别小心,因为它们很廉价
(B) 如果报废,可以不经破坏,直接给废品处理合同商
(C) 不需要像其它原材料那样处理,因为它们很廉价因而不重要
(D) 应当由指定的人按照批准的文件化程序进行发放使用
20. 下列那项是GMP对文件化的要求?
(A) 把药典中原料的标准归入公司批准文件
(B) 告诉人们做什么和什么时候做
(C) 在顾客进行合理投诉时,提供检查追踪线索
(D) 以上全是
21. 一份批生产记录必须包括下列那项:
(A) 产品名称及批号
(B) 关键步骤的日期和时间
(C) 物料平衡
(D) 以上所有答案
22. 在无菌生产区工作的员工应当:
A) 操作上经充分训练
B) 操作、GMP和基础微生物学方面经充分训练
C) 有基础微生物学意识
D) 同其他员工没有区别
23. 疫苗生产的GMP要求:
A) 与其它类型的药物生产要求完全一致
B) 与其它产品的要求完全不同
C) 将常规GMP要求和一些额外的要求结合起来
D) 对大公司和对小公司的要求不同
24. 灭菌方法的验证:
A) 对所有原料灭菌都是必要的
B) 只适用于1990年后被认可的生产过程
C) 仅是一年一度的停产期中完成所有保养后的例行公事
D) 仅是一家工厂在出口其产品前所应当做的事情
25. 无菌区的环境监测应当在下列那种情况下执行:
A) 在验证期间并从那时起按照确定的时间间隔定期进行
B) 只在验证期间
C) 在验证期间并从那时起一季度一次
D) 在验证期间并从那时起一年一次